Costco, like many of its retail rivals, has embraced artificial intelligence (AI). That’s perhaps a little surprising given that the chain has traditionally waited for its rivals to prove the benefits of using emerging technology Read more…
Open enrollment is often viewed as an annual health insurance decision, but it can also have lasting consequences for retirement planning. A recent Vanguard report comparing Flexible Spending Accounts (FSA) and Health Savings Accounts (HSA) Read more…
TheStreet aims to feature only the best products and services. If you buy something via one of our links, we may earn a commission. Why we love this deal Improving your health is one of Read more…
TheStreet aims to feature only the best products and services. If you buy something via one of our links, we may earn a commission. My coupon-clipping days started at a young age, though back then, Read more…
Wall Street just picked a new favorite in the AI chip race, and it isn’t the company most investors expect. According to Investing.com, Cantor Fitzgerald analyst C.J. Muse raised his price target on Advanced Micro Read more…
Warren Buffett issued a sharp warning during Berkshire Hathaway’s annual meeting this year, and its significance extends to every investor watching this market. Speaking to CNBC in an interview during the annual meeting weekend, the Read more…
TheStreet aims to feature only the best products and services. If you buy something via one of our links, we may earn a commission. Why we love this deal Everyday jewelry pieces that make you Read more…
Nvidia (NVDA) may be reaching into its past to solve a very current problem. It looks like the chip giant is resurrecting the GeForce RTX 3060, a graphics card that came out years ago and Read more…
In 1950, petroleum ended coal’s run as the dominant fuel in the United States. That was the last time the top spot in American energy changed hands. 75 years later, it is about to change Read more…
Guardant Health (GH) investors have a new number to think about this week. Bernstein SocGen Group raised its price target on the cancer-screening company’s stock to $200 a share, up from $175. Bernstein also kept Read more…